Advertisement Bolton Medical introduces new Relay Plus delivery system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bolton Medical introduces new Relay Plus delivery system

Bolton Medical, a wholly owned subsidiary of Werfen Life Group, has launched its new Relay Plus, reported to be an improved delivery system, designed for use with the Relay thoracic stent-graft.

According to Bolton Medical, the new delivery system features: hydrophilic coating on outer sheath and tip for easier introduction and advancement through the aorta; longer 60cm braided outer sheath with enhanced radiopacity and reinforced pushrod provides improved push ability and visibility in challenging aortic anatomies; and new nitinol inner catheter provides improved self alignment of the dual sheath system.

Relay Plus was CE marked in March 2009 and is available in Europe and all countries that recognize CE mark certification. It will be marketed along with the Relay thoracic stent-graft which was launched in Europe in 2005 and is well underway in clinical trials in the US.

Relay and Relay NBS endovascular stent-grafts are indicated for the treatment of main thoracic aortic pathologies such as aneurysms, dissections, penetrating ulcers, pseudoaneurysms and intramural hematoma in adult patients.